Don Carleone Sanama B1*, Aatif Taoufiq1, Driss El Kabbaj1, Fatimazahra Fikrat2, Ilyasse Asfalou2 and Aatif Benyass2
1Department of Nephrology-Dialysis-Kidney Transplantation, Mohamed V Military Training Hospital, Rabat, Morocco
2Cardiology Center, Mohamed V Military Training Hospital, Rabat, Morocco
*Corresponding Author: Don Carleone Sanama B, Department of Nephrology-Dialysis-Kidney Transplantation, Mohamed V Military Training Hospital, Rabat, Morocco.
Received: December 06, 2021; Published: February 11, 2022
Introduction: Cardiovascular complications are the leading cause of morbidity and mortality in hemodialysis. Left ventricular hypertrophy (LVH) is an independent factor of cardiovascular morbidity and mortality. Its frequency is 60 to 80% in chronic hemodialysis patients.
Objective: To determine the prevalence of LVH for more adequate cardiovascular management of our patients.
Methods: Observational and analytical cross-sectional study, carried out over a period of six months (February to July 2020), at the Hemodialysis Center of the HMIMV in Rabat. The study population consisted of chronic hemodialysis patients of both sexes, affiliated to the center, placed on conventional hemodialysis for more than three (3) months, and who had received pulsed and continuous Doppler echocardiography 2D. Demographic and clinical-biological data were collected from patient records, supplemented by questioning and listed on a pre-established operating sheet. LVH was defined as LV mass indexed to the body surface or LVMI (g/m2): ≥95 in women and ≥115 in men; The echocardiography was performed by the same operator, within 24 hours of the last dialysis session and data was collected via EchoPac software. The analysis was carried out with SPSS 20.0 software and written with Microsoft Office Word 2013.
Results: The size of our sample was 38 patients, of which 50% were men and 50% were women, for a sex ratio of 1. The mean age was 60.21 ± 16.864. The mean length of time on dialysis was 106.53 ± 72.72. Diabetic nephropathy was the most common in 31.6% of cases. Arterial hypertension was the 2nd CVRF present in 42.1% of cases. 94.7% were on AVF dialysis, and 71.1% had distal AVF. Predialytic hypertension was present in 57.9% of patients. The mean PPID was 4.55 ± 1.25. The mean dry weight was 65.73 ± 11.5. 8 patients (21.1%). The frequency of LVH was 31.6% with a female predominance. Concentric LVH was most common in 23.7% of cases; 36.8% had a concentric remodeling. The mean LVMI was 92.80 ± 28.87 with a maximum LVMI of 164.4 g/m2. 31.6% of patients had Hemoglobin <10 g/dl and the mean PRU was 72.94 ± 6.45.
Conclusion: LVH is very common in chronic hemodialysis patients. Its prevalence is 31.6% in our series. Its early diagnosis by 2D echocardiography must be done systematically. And its multidisciplinary management is important in order to reduce cardiovascular morbidity and mortality.
Keywords: Left Ventricular Hypertrophy (LVH); Hemodialysis; Cardiovascular Complications; HMIMV
Citation: Don Carleone Sanama B., et al. Prevalence of Left Ventricular Hypertrophy in Chronic Hemodialysis Patients of Military Hospital Mohamed V in Rabat”.Acta Scientific Medical Sciences 6.3 (2022): 20-27.
Copyright: © 2022 Don Carleone Sanama B., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.